Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Women's Hospital School Of Medicine Zhejiang University | OTHER |
| Tongji Hospital | OTHER |
| First Affiliated Hospital, Sun Yat-Sen University | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Uterine fibroids are the most common form of benign uterine tumors in the uterine muscle layer, which had a certain rate of malignancy, but it is rare. The prevalence of uterine fibroids estimates range from 4.5% to 68.6% depending on study population and diagnostic methodology. The prevalence of fibroids has been historically underestimated by epidemiologic studies which focused mainly on symptomatic women, leaving behind a large population of asymptomatic women and women who underreport their symptoms. What investigators don't know was which women who have fibroids will develop clinical symptoms and which women who have an operation of myomectomy will relapse. The purpose of this study is to investigate the prevalence, incidence and risk factors for the development of uterine fibroids in Chinese women.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of uterine fibroids in China | Prevalence of uterine fibroids in China | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of uterine fibroids in China | Incidence of uterine fibroids in China | Two follow-ups over a three-year period |
| Risk factors of development of uterine fibroids in China | Associated risk factors for recurrence, infertility and malignancy of uterine fibroids in China |
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
This study population is women aged more than 18yrs with or without uterine fibroids from five regions of China. The study time period will conduct from May 1, 2023 - November 30, 2025 to allow for 6 months pre-index for evaluating baseline demographic and clinical characteristics and 24 months post-index, ensuring a minimum of one years follow-up.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| WENWEN WANG, DOCTOR | Contact | 15927167698 | petrawang@163.com | |
| MINLI ZHANG, MASTER | Contact |
| Name | Affiliation | Role |
|---|---|---|
| SHIXUAN WANG, DOCTOR | Huazhong University of Science and Technology | Principal Investigator |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38233053 | Derived | Yan W, Yuan S, Zhou D, Zhang M, Yang S, Wang W, Wang S. Status and treatment of patients with uterine fibroids in hospitals in central China: a retrospective study from 2018 to 2021. BMJ Open. 2024 Jan 17;14(1):e081736. doi: 10.1136/bmjopen-2023-081736. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007889 | Leiomyoma |
| ID | Term |
|---|---|
| D009379 | Neoplasms, Muscle Tissue |
| D018204 | Neoplasms, Connective and Soft Tissue |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
Not provided
Not provided
| West China Hospital |
| OTHER |
| The Fourth Hospital of Shijiazhuang | OTHER |
Not provided
Not provided
Not provided
| Two follow-ups over a three-year period |